DE3751593D1 - IL-1 beta Derivate und Medikamente. - Google Patents

IL-1 beta Derivate und Medikamente.

Info

Publication number
DE3751593D1
DE3751593D1 DE3751593T DE3751593T DE3751593D1 DE 3751593 D1 DE3751593 D1 DE 3751593D1 DE 3751593 T DE3751593 T DE 3751593T DE 3751593 T DE3751593 T DE 3751593T DE 3751593 D1 DE3751593 D1 DE 3751593D1
Authority
DE
Germany
Prior art keywords
drugs
beta derivatives
beta
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3751593T
Other languages
English (en)
Other versions
DE3751593T2 (de
Inventor
Satoru Nakai
Mayumi Kaneta
Yoshikazu Kikumoto
Yeong-Man Hong
Kazuyoshi Kawai
Setsuko Takegata
Kiyoshi Ishii
Yasuo Yanagihara
Yoshikatsu Hirai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE3751593D1 publication Critical patent/DE3751593D1/de
Publication of DE3751593T2 publication Critical patent/DE3751593T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/545—IL-1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE3751593T 1986-03-14 1987-03-12 IL-1 beta Derivate und Medikamente. Expired - Fee Related DE3751593T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP5788586 1986-03-14
JP14583086 1986-06-20
JP16118486 1986-07-09
JP20032486 1986-08-27

Publications (2)

Publication Number Publication Date
DE3751593D1 true DE3751593D1 (de) 1995-12-21
DE3751593T2 DE3751593T2 (de) 1996-03-28

Family

ID=27463573

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3751593T Expired - Fee Related DE3751593T2 (de) 1986-03-14 1987-03-12 IL-1 beta Derivate und Medikamente.

Country Status (5)

Country Link
EP (2) EP0569042A1 (de)
JP (1) JP2591615B2 (de)
DE (1) DE3751593T2 (de)
DK (1) DK171648B1 (de)
ES (1) ES2009215A6 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047505A (en) * 1987-01-27 1991-09-10 Du Pont Merck Pharmaceutical Company High level expression in E. coli of soluble mature HIL-1beta and derivatives with altered biological activity
US4904584A (en) * 1987-12-23 1990-02-27 Genetics Institute, Inc. Site-specific homogeneous modification of polypeptides
JP2698976B2 (ja) * 1988-02-03 1998-01-19 大日本製薬株式会社 新規ポリペプチド及びそれをコードするｄｎａ
EP0644203A1 (de) * 1988-07-29 1995-03-22 Otsuka Pharmaceutical Co., Ltd. IL-1 alpha Derivate und Arzneimittel gegen Thrombozytopenie
JP2554528B2 (ja) * 1988-09-19 1996-11-13 大塚製薬株式会社 副腎皮質刺激ホルモン分泌能検査薬
DE68916237T2 (de) * 1988-12-06 1994-11-10 Otsuka Pharma Co Ltd Stabilisierte interleukin-1-beta enthaltende zusammensetzung.
US5039790A (en) * 1989-01-11 1991-08-13 Monsanto Company Bioactive fragment of interleukin-1-B that has antagonistic activity
AU5171890A (en) * 1989-02-27 1990-09-26 Massachusetts Institute Of Technology Il-1 biological activity inhibitors
DE69126116T2 (de) * 1990-08-10 1997-08-28 Otsuka Pharma Co Ltd Wirkstoff zur hepatitisverhütung und -behandlung
JP2678689B2 (ja) * 1990-08-10 1997-11-17 大塚製薬株式会社 肝炎予防・治療剤
US5723117A (en) * 1990-08-10 1998-03-03 Otsuka Pharmaceutical Co., Ltd. Use of interleukin-1 (IL-1) to inhibit development of hepatitis
FR2667601A1 (fr) * 1990-10-05 1992-04-10 Rhone Poulenc Sante Polypeptides derives de l'interleukine-1 beta, procede de preparation et utilisation, notamment dans le cadre des pathologies osteoarticulaires.
AU1270592A (en) * 1991-02-05 1992-09-07 University Of Maryland Modified interleukin-1beta
SE9201966D0 (sv) * 1992-06-25 1992-06-25 Trion Forskning & Utveckling Interleukin-1beta deletion mutant
GB9916630D0 (en) * 1999-07-16 1999-09-15 Univ Manchester Molecules derived from interleukins
ATE413191T1 (de) * 1999-12-03 2008-11-15 Celltech Chiroscience Ltd Verwendung of interleukin-1 mutein als impfstoffadjuvans
WO2002017958A1 (de) * 2000-08-29 2002-03-07 Max-Delbrück-Centrum für Molekulare Medizin Mittel zur beeinflussung der angiogenese
WO2005084198A2 (en) * 2004-02-27 2005-09-15 Vaxconsulting Peptides of il1 beta and tnf alpha and method of treatment using same
UA99990C2 (uk) * 2009-03-17 2012-10-25 Общєство С Огранічєнной Отвєтствєнностью "Сєнгара" Інтерлейкін-1 бета в косметичних композиціях і способи його використання

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816436A (en) * 1986-10-29 1989-03-28 Immunex Corporation Anti-arthritic use of interleukin-1 proteins

Also Published As

Publication number Publication date
EP0237967A3 (en) 1990-03-28
EP0237967B1 (de) 1995-11-15
EP0569042A1 (de) 1993-11-10
DK171648B1 (da) 1997-03-03
DE3751593T2 (de) 1996-03-28
EP0237967A2 (de) 1987-09-23
DK127887A (da) 1987-09-15
JP2591615B2 (ja) 1997-03-19
JPS63152398A (ja) 1988-06-24
ES2009215A6 (es) 1989-09-16
DK127887D0 (da) 1987-03-12

Similar Documents

Publication Publication Date Title
DE3750432D1 (de) IL-1 alpha Derivate und Medikamente.
DE3786606D1 (de) Stabilisiertes benzimidazol-derivat und zusammenstellung.
NL300038I2 (nl) Thiazolidinedionderivaten, alsmede bereiding en toepassing daarvan.
DE3751593D1 (de) IL-1 beta Derivate und Medikamente.
NO872155L (no) Tetrahydronaftalin- og indanderivater.
NO872939D0 (no) Tetrahydronaftalin- og indanderivater.
NO862651D0 (no) Fremgangsmaate for fremstilling av isoksazol- og furanderivater.
NL970029I2 (nl) Benzimidazoolderivaten, bereiding en therapeutische toepassing.
DK254488A (da) Azaindol- og indolizinderivater
DE3667782D1 (de) Perfluorcycloalkancarbonylfluoride und deren derivate.
DE3583765D1 (de) Hydantoinderivate und diese enthaltende pharmazeutische zusammensetzungen.
DE3671446D1 (de) 5-aralkylsubstituierte 2h-benztriazole und stabilisierte zusammensetzungen.
DE68909501D1 (de) Hydroxyalkylcystein-derivate und diese enthaltende expectoranzien.
DE3789963D1 (de) Menschliche tachykinine und ihre vorläufer.
DE3881576D1 (de) Anthracyclinderivate und ihre verwendung.
FI860209A0 (fi) Engaongselektrod foer undersoekning av en patient.
DE3680771D1 (de) Isoxazolopyridophenoxazin- und isothiazolopyridophenoxazinderivate.
DK527487D0 (da) Farmaceutiske praeparater med forlaenget afgivelse
DE3787669D1 (de) Substanz 4181-2 und deren Derivate.
DE3770718D1 (de) P-hydroxyzimtamid derivate und diese enthaltende melanininhibitoren.
DE3674017D1 (de) Oxalursaeure-derivate und pharmazeutisches mittel.
DE3680775D1 (de) Isoxazolopyridobenzoxazin- und isothiazolopyridobenzoxazinderivate.
FI875616A0 (fi) Farmaceutiska blandningar.
DE3689036D1 (de) Lankacidinderivate und ihre Herstellung.
TR24945A (tr) IMIDOZAL TüREVLERI BU TüREVLERIN HAZIRLANISI VE FUNGISIT OLARAK KULLANILMALARI

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee